N-acetyl-cysteine reduces the risk for mechanical ventilation and mortality in patients with COVID-19 pneumonia: a two-center retrospective cohort study

References

• Mehta P, McAuley DF, Brown M, et al.; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–1034.
   PubMed Web of Science ®Google Scholar
• Conner EM, Grisham MB. Inflammation, free radicals, and antioxidants. Nutrition. 1996;12(4):274–277.
   PubMed Web of Science ®Google Scholar
• COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Available from: https://www.covid19treatmentguidelines.nih.gov/
   Google Scholar
• Zhang Q, Ju Y, Ma Y, et al. N-acetylcysteine improves oxidative stress and inflammatory response in patients with community acquired pneumonia: a randomized controlled trial. Medicine (Baltimore). 2018;97(45):e13087.
   PubMed Web of Science ®Google Scholar
• Sanguinetti CM. N-acetylcysteine in COPD: why, how, and when? Multidiscip Respir Med. 2015;11:8.
   PubMed Web of Science ®Google Scholar
• Millea PJ. N-acetylcysteine: multiple clinical applications. Am Fam Physician. 2009;80(3):265–269.
   PubMed Web of Science ®Google Scholar
• Selcuk M, Cinar T, Keskin M, et al. Is the use of ACE inb/ARBs associated with higher in-hospital mortality in Covid-19 pneumonia patients? Clin Exp Hypertens. 2020;42(8):738–742.
   PubMed Web of Science ®Google Scholar
• Wang Z, Wang Z. Identification of risk factors for in-hospital death of COVID-19 pneumonia - lessions from the early outbreak. BMC Infect Dis. 2021;21(1):113.
   PubMed Web of Science ®Google Scholar
• de Souza FSH, Hojo-Souza NS, Batista B. D d O, et al. On the analysis of mortality risk factors for hospitalized COVID-19 patients: A data-driven study using the major Brazilian database. PLoS One. 2021;16(3):e0248580.
   PubMed Web of Science ®Google Scholar
• Northrop-Clewes CA. Interpreting indicators of iron status during an acute phase response-lessons from malaria and human immunodeficiency virus. Ann Clin Biochem. 2008;45(Pt 1):18–32.
   PubMedGoogle Scholar
• Sharafkhah M, Abdolrazaghnejad A, Zarinfar N, et al. Safety and efficacy of N-acetyl-cysteine for prophylaxis of ventilator-associated pneumonia: a randomized, double blind, placebo-controlled clinical trial. Med Gas Res. 2018;8(1):19–23.
   PubMed Web of Science ®Google Scholar
• Liu Y, Yao W, Xu J, et al. The anti-inflammatory effects of acetaminophen and N-acetylcysteine through suppression of the NLRP3 inflammasome pathway in LPS-challenged piglet mononuclear phagocytes. Innate Immun. 2015;21(6):587–597.
   PubMed Web of Science ®Google Scholar
• Lee SI, Kang KS. N-acetylcysteine modulates lipopolysaccharide-induced intestinal dysfunction. Sci Rep. 2019;9(1):1004.
   PubMedGoogle Scholar
• Assimakopoulos SF, Maroulis I, Patsoukis N, et al. Effect of antioxidant treatments on the gut-liver axis oxidative status and function in bile duct-ligated rats. World J Surg. 2007;31(10):2023–2032.
   PubMed Web of Science ®Google Scholar
• Sirivongrangson P, Kulvichit W, Payungporn S, et al. Endotoxemia and circulating bacteriome in severe COVID-19 patients. Intensive Care Med Exp. 2020;8(1):72.
   PubMed Web of Science ®Google Scholar
• Scheffel MJ, Scurti G, Wyatt MM, et al. N-acetyl cysteine protects anti-melanoma cytotoxic T cells from exhaustion induced by rapid expansion via the downmodulation of Foxo1 in an Akt-dependent manner. Cancer Immunol Immunother. 2018;67(4):691–702.
   PubMed Web of Science ®Google Scholar
• Mata M, Morcillo E, Gimeno C, et al. N-acetyl-L-cysteine (NAC) inhibit mucin synthesis and pro-inflammatory mediators in alveolar type II epithelial cells infected with influenza virus A and B and with respiratory syncytial virus (RSV). Biochem Pharmacol. 2011;82(5):548–555.
   PubMed Web of Science ®Google Scholar
• Shi Z, Puyo CA. N-acetylcysteine to combat COVID-19: an evidence review. Ther Clin Risk Manag. 2020;16:1047–1055.
   PubMed Web of Science ®Google Scholar
• de Alencar JCG, Moreira CL, Muller AD, et al. Double-blind, randomized, placebo-controlled trial with N-acetylcysteine for treatment of severe acute respiratory syndrome caused by COVID-19. Clin Infect Dis. 2020;72(11):e736–e741.
   Web of Science ®Google Scholar
• Horowitz RI, Freeman PR, Bruzzese J. Efficacy of glutathione therapy in relieving dyspnea associated with COVID-19 pneumonia: A report of 2 cases. Respir Med Case Rep. 2020;30:101063.
   PubMed Web of Science ®Google Scholar
• Ibrahim H, Perl A, Smith D, et al. Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine. Clin Immunol. 2020;219:108544.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Ding S, Li C, et al. Effects of N-acetylcysteine treatment in acute respiratory distress syndrome: A meta-analysis. Exp Ther Med. 2017;14(4):2863–2868.
   PubMed Web of Science ®Google Scholar
• Sotler R, Poljsak B, Dahmane R, et al. Prooxidant Activities of Antioxidants and Their Impact on Health. Acta Clin Croat. 2019;58(4):726–736.
   PubMed Web of Science ®Google Scholar
• Sagrista ML, Garcia AE, Africa De Madariaga M, et al. Antioxidant and pro-oxidant effect of the thiolic compounds N-acetyl-L-cysteine and glutathione against free radical-induced lipid peroxidation. Free Radic Res. 2002;36(3):329–340.
   PubMed Web of Science ®Google Scholar
• Harvey BH, Joubert C, Du Preez JL, et al. Effect of chronic N-acetyl cysteine administration on oxidative status in the presence and absence of induced oxidative stress in rat striatum. Neurochem Res. 2008;33(3):508–517.
   PubMed Web of Science ®Google Scholar
• Takahashi N, Yoshida T, Ohnuma A, et al. The enhancing effect of the antioxidant N-acetylcysteine on urinary bladder injury induced by dimethylarsinic acid. Toxicol Pathol. 2011;39(7):1107–1114.
   PubMed Web of Science ®Google Scholar